Manage episode 493049747 series 2437481
I am honored to reconnect with Dr. Tracy Gapin today. He is a board-certified urologist and men’s health expert.
The current state of metabolic health in the United States and most Westernized countries has sparked a great interest in a GLP1 agonist, AKA Semaglutide Ozempic. I wanted to speak with a clinician who actively uses this medication.
Dr. Gapin and I discuss what this drug class represents. (These are synthetic peptides.) We speak about Semaglutide, Ozempic, Wegovy, and oral Rybelsus. We get into current research, side effects, who should not take these medications, the mechanisms of action specific to the pancreas and beta cells, reductions, gastric emptying, and the upregulation of satiety. We discuss changes in the brain regarding leptin and how these drugs work. We also talk about weight loss resistance, and I answer questions from listeners.
From my perspective, it all comes back to basics. I believe that if we are to prescribe these medications, we must help our patients understand how lifestyle impacts weight-loss resistance and metabolic health. I loved that Dr. Tracy spent some time talking about the specific ways he works with his patients, even before prescribing medications. He also explains how important he feels this drug has been for his patients.
I approached today’s conversation with an open mind, and I hope you will do the same.
IN THIS EPISODE YOU WILL LEARN:
GLP1 agonists, and how they help Dr. Tracy motivate his patients to lose weight
What are GLP1 agonists, and how do they work?
Physical benefits of GLP1 agonists
Who is Semaglutide not appropriate for?
Common side-effects of GLP1 agonists
How those who fail to implement lifestyle changes when they stop using Semaglutide may regain all the weight they lost
Hydration while using Semaglutide
Protein intake when taking Semaglutide
How to follow the metrics that matter
Factors that could hinder successful weight loss
What Dr. Tracy does to ensure his patients do not regain the weight they lost after they stop using Semaglutide
Listener questions:
Why is a diabetic drug being used for non-diabetics?
Does this drug target muscle versus fat in terms of weight loss?
For how long do most patients take it?
Are there unique characteristics in perimenopausal and menopausal women that must be accounted for differently?
Bio:
Dr. Tracy Gapin is a board-certified urologist and a world-renowned expert in men’s health and performance, as well as the founder of the Gapin Institute, the global leader in High-Performance Health.
He has over 20 years of experience focused on men’s health optimization, human performance, and longevity, providing executives & entrepreneurs a personalized path to fulfill their highest potential. He’s been featured in Entrepreneur, Dave Asprey’s Biohacking Conference, and as a TEDx speaker.
Connect with Cynthia Thurlow
Follow on Twitter, Instagram & LinkedIn
Check out Cynthia’s website
Connect with Tracy Gapin
On his website
546 episodes